Crossmark

Adjuvant Chemotherapy Does Not Compensate for an Inadequate Right Colon Cancer Surgery: High Peritoneal Recurrence Rates Indicate Need for Altered Treatment Paradigms

Crossref DOI link: https://doi.org/10.1007/s13193-024-02099-2

Published Online: 2024-09-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patel, Swapnil

Kazi, Mufaddal

Mohan, Anand

Sukumar, Vivek

deSouza, Ashwin L.

Saklani, Avanish https://orcid.org/0000-0003-4498-7612
Funding

Funding for this research was provided by:

Tata Memorial Hospital - TMC
License Information

Text and Data Mining valid from 2024-09-25

Version of Record valid from 2024-09-25
More Information

Article History

Received: 29 July 2024

Accepted: 14 September 2024

First Online: 25 September 2024

Declarations

:

: The manuscript has been reviewed by the Institutional Ethics Committee and has been performed in accordance with the ethical standards laid down in the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below